Drugs & Targets Health Canada approves Imbruvica in Waldenström’s macroglobulinemia May 13, 2016Vol.42 No.19
Drugs & Targets FDA Expands Imbruvica Label To Include CLL and SLL Patients May 13, 2016Vol.42 No.19
Drugs & Targets Health Canada grants conditional approval to Ibrance in breast cancer May 13, 2016Vol.42 No.19
CMS Drug Payment Experiment Heads Toward Showdown on Capitol Hill May 13, 2016Vol.42 No.19By Paul Goldberg
Drugs & Targets AbbVie and CytomX Therapeutics to collaborate on probody drug conjugates May 06, 2016Vol.42 No.18
